Response evaluation of the neck in oropharyngeal cancer: Value of magnetic resonance imaging and influence of p16 in selecting patients for post-radiotherapy neck dissection

References

• Sandulache VC, Ow TJ, Daram SP, Hamilton J, Skinner H, Bell D, et al. Residual nodal disease in patients with advanced-stage oropharyngeal squamous cell carcinoma treated with definitive radiation therapy and posttreatment neck dissection: Association with locoregional recurrence, distant metastasis, and decreased survival. Head Neck 2013;35:1454–60.
   PubMed Web of Science ®Google Scholar
• Ferlito A, Corry J, Silver CE, Shaha AR, Thomas Robbins K, Rinaldo A. Planned neck dissection for patients with complete response to chemoradiotherapy: A concept approaching obsolescence. Head Neck 2010;32:253–61.
   PubMed Web of Science ®Google Scholar
• Hermann RM, Christiansen H, Rödel RM. Lymph node positive head and neck carcinoma after curative radiochemotherapy: A long lasting debate on elective post-therapeutic neck dissections comes to a conclusion. Cancer Radiother 2013;17:323–31.
   PubMed Web of Science ®Google Scholar
• Lassen P. The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome. Radiother Oncol 2010;95:371–80.
   PubMed Web of Science ®Google Scholar
• Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011;29:4294–301.
   PubMed Web of Science ®Google Scholar
• Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24–35.
   PubMed Web of Science ®Google Scholar
• Lassen P, Primdahl H, Johansen J, Kristensen CA, Andersen E, Andersen LJ, et al. Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer. Radiother Oncol 2014;113:310–6.
   PubMed Web of Science ®Google Scholar
• Lassen P, Overgaard J. Scoring and classification of oropharyngeal carcinoma based on HPV-related p16-expression. Radiother Oncol 2012;105:269–70.
   PubMed Web of Science ®Google Scholar
• Strasser MD, Gleich LL, Miller MA, Saavedra HI, Gluckman JL. Management implications of evaluating the N2 and N3 neck after organ preservation therapy. Laryngoscope 1999;109:1776–80.
   PubMed Web of Science ®Google Scholar
• VanderWalde N, Salloum RG, Liu T-L, Hornbrook MC, O’Keeffe Rosetti MC, Ritzwoller DP, et al. Positron emission tomography and stage migration in head and neck cancer. JAMA Otolaryngol Neck Surg 2014;140:654.
   PubMed Web of Science ®Google Scholar
• Mendenhall WM, Villaret DB, Amdur RJ, Hinerman RW, Mancuso AA. Planned neck dissection after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck 2002;24:1012–8.
   PubMed Web of Science ®Google Scholar
• Johansen LV, Grau C, Overgaard J. Squamous cell carcinoma of the oropharynx – an analysis of treatment results in 289 consecutive patients. Acta Oncol 2000;39:985–94.
   PubMed Web of Science ®Google Scholar
• Johansen LV, Grau C, Overgaard J. Nodal control and surgical salvage after primary radiotherapy in 1782 patients with laryngeal and pharyngeal carcinoma. Acta Oncol 2004;43:486–94.
   PubMed Web of Science ®Google Scholar
• Bentzen J, Toustrup K, Eriksen JG, Primdahl H, Andersen LJ, Overgaard J. Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study. Acta Oncol 2015;54:1001–7.
   Google Scholar
• Van der Putten L, van den Broek GB, de Bree R, van den Brekel MWM, Balm AJM, Hoebers FJP, et al. Effectiveness of salvage selective and modified radical neck dissection for regional pathologic lymphadenopathy after chemoradiation. Head Neck 2009;31:593–603.
   PubMed Web of Science ®Google Scholar
• Davidson BJ, Newkirk KA, Harter KW, Picken CA, Cullen KJ, Sessions RB. Complications from planned, posttreatment neck dissections. Arch Otolaryngol Head Neck Surg 1999;125:401–5.
   PubMed Web of Science ®Google Scholar
• Genden E, Ferlito A, Shaha A, Talmi Y, Robins K, Rhys-Evans P, et al. Complications of neck dissection. Acta Otolaryngol 2003;123:795–801.
   PubMed Web of Science ®Google Scholar
• Mabanta SR, Mendenhall WM, Stringer SP, Cassisi NJ. Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes. Head Neck 1999;21:591–4.
   PubMed Web of Science ®Google Scholar
• Schwartz LH, Bogaerts J, Ford R, Shankar L, Therasse P, Gwyther S, et al. Evaluation of lymph nodes with RECIST 1.1. Eur J Cancer 2009;45:261–7.
   PubMed Web of Science ®Google Scholar
• Huang SH, O’Sullivan B, Xu W, Zhao H, Chen DD, Ringash J, et al. Temporal nodal regression and regional control after primary radiation therapy for N2-N3 head- and-neck cancer stratified by HPV status. Int J Radiat Oncol Biol Phys 2013;87:1078–85.
   PubMed Web of Science ®Google Scholar
• De Bree R, van der Putten L, Brouwer J, Castelijns JA, Hoekstra OS, Leemans CR. Detection of locoregional recurrent head and neck cancer after (chemo)radiotherapy using modern imaging. Oral Oncol 2009;45:386–93.
   PubMed Web of Science ®Google Scholar
• Gupta T, Jain S, Agarwal JP, Rangarajan V, Purandare N, Ghosh-Laskar S, et al. Diagnostic performance of response assessment FDG-PET/CT in patients with head and neck squamous cell carcinoma treated with high-precision definitive (chemo)radiation. Radiother Oncol 2010; 97:194–9.
   PubMed Web of Science ®Google Scholar
• Isles MG, McConkey C, Mehanna HM. A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol 2008;33:210–22.
   PubMed Web of Science ®Google Scholar
• Ampil F, Caldito G, Reiser C, Devarakonda S, Takalkar A, Nathan C-A, et al. The prognostic utility of 18 F-FDG-PET metabolic tumor response after chemoradiotherapy for locally advanced head and neck cancer. Acta Oncol 2015;54: 1066–7.
   PubMed Web of Science ®Google Scholar
• Tan M. Timing of restaging PET/CT and neck dissection after chemoradiation for advanced head and neck squamous cell carcinoma. Otolaryngology 2013;3:1–6.
   Google Scholar